{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:10:24Z","timestamp":1772050224890,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaccas.2024.102761","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T23:25:33Z","timestamp":1733354733000},"page":"102761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Managing Myotonic Dystrophy Type 1 Complicated by Metabolic Syndrome"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7067-279X","authenticated-orcid":false,"given":"Gianluca","family":"Pagnoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Grossule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Maini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1487-9530","authenticated-orcid":false,"given":"Anna Vittoria","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Coppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaccas.2024.102761_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jacl.2021.05.002","article-title":"Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin\/kexin type 9 inhibitor therapy: a randomized, controlled trial","volume":"15","author":"Rubino","year":"2021","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jaccas.2024.102761_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8490242","article-title":"Ultrasound grade of liver steatosis is independently associated with the risk of metabolic syndrome","volume":"2018","author":"Mustapic","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"15","key":"10.1016\/j.jaccas.2024.102761_bib3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.jaccas.2024.102761_bib4","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.03.019","article-title":"Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab","volume":"63","author":"Stroes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jaccas.2024.102761_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jaccas.2024.102761_bib6","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/ijerph18041794","article-title":"Metabolic alterations in myotonic dystrophy type 1 and their correlation with lipin","volume":"18","author":"Mateus","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1016\/j.jaccas.2024.102761_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/fca-2021-0011","article-title":"Cardiovascular disease prevention and therapy in women with Type 2 diabetes","volume":"17","author":"Cocchi","year":"2021","journal-title":"Future Cardiol"},{"key":"10.1016\/j.jaccas.2024.102761_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.686735","article-title":"CTG-repeat detection in primary human myoblasts of myotonic dystrophy type 1","volume":"15","author":"Hintze","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jaccas.2024.102761_bib9","article-title":"Physical activity, sedentary behaviour, and diet in menopausal women: comparison between COVID19 \u201cfirst wave\u201d and \u201csecond wave\u201d of pandemic in Italy","volume":"23","author":"Coppi","year":"2021","journal-title":"Prog Nutr"},{"issue":"1","key":"10.1016\/j.jaccas.2024.102761_bib10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/07853890.2022.2059559","article-title":"Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis","volume":"54","author":"Tummala","year":"2022","journal-title":"Ann Med"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084924007976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084924007976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:12:15Z","timestamp":1734135135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084924007976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":10,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2666084924007976"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2024.102761","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing Myotonic Dystrophy Type 1 Complicated by Metabolic Syndrome","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2024.102761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102761"}}